These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16452582)

  • 1. Limitation of cigarette consumption by CYP2A6*4, *7 and *9 polymorphisms.
    Minematsu N; Nakamura H; Furuuchi M; Nakajima T; Takahashi S; Tateno H; Ishizaka A
    Eur Respir J; 2006 Feb; 27(2):289-92. PubMed ID: 16452582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association between smoking and CYP2A6 gene polymorphisms in A Japanese population.
    Zhang X; Amemo K; Ameno S; Iwahashi K; Kinoshita H; Kubota T; Mostofa J; Ijiri I
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2001 Oct; 36(5):486-90. PubMed ID: 11725533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of CYP2A6 gene deletion with cigarette smoking status in Japanese adults.
    Ando M; Hamajima N; Ariyoshi N; Kamataki T; Matsuo K; Ohno Y
    J Epidemiol; 2003 May; 13(3):176-81. PubMed ID: 12749606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CYP2A6*1B genetic variant with the amount of smoking in French adults from the Stanislas cohort.
    Gambier N; Batt AM; Marie B; Pfister M; Siest G; Visvikis-Siest S
    Pharmacogenomics J; 2005; 5(4):271-5. PubMed ID: 15940289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers.
    Fujieda M; Yamazaki H; Saito T; Kiyotani K; Gyamfi MA; Sakurai M; Dosaka-Akita H; Sawamura Y; Yokota J; Kunitoh H; Kamataki T
    Carcinogenesis; 2004 Dec; 25(12):2451-8. PubMed ID: 15308589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers.
    Ariyoshi N; Miyamoto M; Umetsu Y; Kunitoh H; Dosaka-Akita H; Sawamura Y; Yokota J; Nemoto N; Sato K; Kamataki T
    Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):890-4. PubMed ID: 12223434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.
    Schoedel KA; Hoffmann EB; Rao Y; Sellers EM; Tyndale RF
    Pharmacogenetics; 2004 Sep; 14(9):615-26. PubMed ID: 15475735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.
    Kubota T; Nakajima-Taniguchi C; Fukuda T; Funamoto M; Maeda M; Tange E; Ueki R; Kawashima K; Hara H; Fujio Y; Azuma J
    Pharmacogenomics J; 2006; 6(2):115-9. PubMed ID: 16402086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analytic review of the CYP2A6 genotype and smoking behavior.
    Carter B; Long T; Cinciripini P
    Nicotine Tob Res; 2004 Apr; 6(2):221-7. PubMed ID: 15203795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2A6 polymorphism reveals differences in Japan and the existence of a specific variant in Ovambo and Turk populations.
    Takeshita H; Hieda Y; Fujihara J; Xue Y; Nakagami N; Takayama K; Imamura S; Kataoka K
    Hum Biol; 2006 Apr; 78(2):235-42. PubMed ID: 17036930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CYP2A6 deletion polymorphism with smoking habit and development of pulmonary emphysema.
    Minematsu N; Nakamura H; Iwata M; Tateno H; Nakajima T; Takahashi S; Fujishima S; Yamaguchi K
    Thorax; 2003 Jul; 58(7):623-8. PubMed ID: 12832682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking behavior and related cancers: the role of CYP2A6 polymorphisms.
    Nakajima M
    Curr Opin Mol Ther; 2007 Dec; 9(6):538-44. PubMed ID: 18041664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The relationship between smoking behavior in young people and CYP2A6 gene polymorphisms, between them and personality traits assessed by NEO-FFI].
    Waga C; Iwahashi K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2006 Aug; 41(4):380-6. PubMed ID: 17037346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism.
    Yoshida R; Nakajima M; Watanabe Y; Kwon JT; Yokoi T
    Br J Clin Pharmacol; 2002 Nov; 54(5):511-7. PubMed ID: 12445030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking.
    Rao Y; Hoffmann E; Zia M; Bodin L; Zeman M; Sellers EM; Tyndale RF
    Mol Pharmacol; 2000 Oct; 58(4):747-55. PubMed ID: 10999944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2A6 genetic polymorphisms and correlation with smoking status in Brazilians.
    Vasconcelos GM; Struchiner CJ; Suarez-Kurtz G
    Pharmacogenomics J; 2005; 5(1):42-8. PubMed ID: 15534625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cigarette smoking and exposure to cadmium and lead on phenotypic variability of hepatic CYP2A6 and renal function biomarkers in men.
    Satarug S; Ujjin P; Vanavanitkun Y; Nishijo M; Baker JR; Moore MR
    Toxicology; 2004 Nov; 204(2-3):161-73. PubMed ID: 15388242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole deletion of CYP2A6 gene (CYP2A6AST;4C) and smoking behavior.
    Iwahashi K; Waga C; Takimoto T
    Neuropsychobiology; 2004; 49(2):101-4. PubMed ID: 14981342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of the rate of nicotine metabolism and effects on smoking behavior.
    Johnstone E; Benowitz N; Cargill A; Jacob R; Hinks L; Day I; Murphy M; Walton R
    Clin Pharmacol Ther; 2006 Oct; 80(4):319-30. PubMed ID: 17015050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An association of CYP2A6 genotype and smoking topography.
    Strasser AA; Malaiyandi V; Hoffmann E; Tyndale RF; Lerman C
    Nicotine Tob Res; 2007 Apr; 9(4):511-8. PubMed ID: 17454707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.